CRCanara Robeco MFRegular · Growth

Canara Robeco Balanced Advantage Fund - Regular Plan - Growth

hybridHybrid - Balanced AdvantageBenchmark: CRISIL Hybrid 50+50 - Moderate Index
NAV · 16 Sep 2026₹10.06+0.10%
AUM₹1.1k Cr
Expense Ratio2.38%
1Y CAGR-2.52%
Exit LoadNil upto 12% of units and 1% for remaining units on or before 365D, Nil after 365D
Min SIP₹1,000
Launched2024

Investment Objective

The scheme aims to generate long-term capital appreciation with income generation by dynamically investing in equity and equity related instruments and debt and money market instruments. However, there can be no assurance that the investment objective of the scheme will be realized.

Fund Mandate

Debt & MMI0%–35%
Equity & Equity-related Instruments65%–100%
Asset Allocation
Domestic Equity77.8%
Debt18.8%
Cash & Equivalents3.5%
Fund Managers
EF
Ennettee Fernandes
Fund Manager
Key Information
2.38%
₹1,000
₹5,000
Nil upto 12% of units and 1% for remaining units on or before 365D, Nil after 365D
Nil
Inception02 Aug 2024
AMCCanara Robeco MF
Top Holdings
1HDFC Bank LtdBanks5.52%
2ICICI Bank LtdBanks5.25%
3Reliance Industries LtdPetroleum Products4.59%
4Bharti Airtel LtdTelecom - Services3.29%
5Larsen & Toubro LtdConstruction3.13%
6Axis Bank LtdBanks2.79%
7TREPS2.75%
8State Bank of IndiaBanks2.41%
9Infosys LtdIT - Software2.34%
107.74% LIC Housing Finance Ltd (22/10/2027) **2.32%
Sector Allocation
Other20.1%
Banks16.0%
Petroleum Products4.6%
Telecom - Services3.3%
Construction3.1%
IT - Software2.3%
Retailing2.3%
Auto Components2.1%
Automobiles2.1%
Latest News

No recent news found for Canara Robeco Balanced Advantage Fund - Regular Plan - Growth.

Canara Robeco MF Latest News

Trailing Returns
PeriodReturnsCategory avg
1 Day+0.10%
1 Week-1.76%-1.91%
1 Month-3.27%-3.06%
3 Months-0.20%+0.26%
6 Months+3.61%+4.44%
9 Months-4.01%-1.13%
1 Year-2.52%+0.92%
2 Years-1.60%+1.59%
+0.24%+9.20%

Category avg is the average return of every scheme in this fund's SEBI class (Hybrid - Balanced Advantage) over the same period. Return basis follows each class's underlying asset type, so it varies within this category: absolute or annualised up to 1 year, CAGR beyond.

Risk Metrics
9.66%

A measure of how much a fund's returns swing up and down over time. Higher means a bumpier ride — more volatility — even if the average return ends up the same as a steadier fund.

0.71

How sensitive a fund is to overall market moves. A beta of 1 means it roughly moves in line with the market; below 1 means smaller swings than the market; above 1 means bigger swings in both directions.

-0.57

How much extra return a fund earned for every unit of risk (volatility) it took on, compared to a safe, risk-free investment. Higher means better risk-adjusted performance — not just higher returns, but smarter ones.

-0.26%

The extra return a fund generated above what its benchmark index would predict, given the risk it took. Positive alpha suggests the fund manager added genuine value beyond just tracking the market.

-0.92

Similar to the Sharpe Ratio, but only counts downside volatility (the bad kind) rather than penalizing a fund for volatile-but-positive swings. Higher means better returns per unit of "harmful" risk.

-8.57%

The single worst peak-to-trough fall a fund has experienced over a given period — the deepest "how much would I have lost if I'd bought at the top and sold at the bottom" scenario.

Fees
2.38%
Nil upto 12% of units and 1% for remaining units on or before 365D, Nil after 365D
Nil
₹1,000
₹5,000
Capital Gains Tax, general rules

This is a debt/other (non-equity-oriented) fund. For units acquired on or after 1 April 2023, gains are taxed at your applicable income-tax slab rate regardless of holding period, the earlier long-term/indexation treatment for debt funds was removed by the Finance Act 2023.

General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.

Frequently Asked QuestionsGeneral mutual-fund FAQs, not specific to this scheme